BR0210746A - Derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina tendo atividade antiviral - Google Patents

Derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina tendo atividade antiviral

Info

Publication number
BR0210746A
BR0210746A BR0210746-5A BRPI0210746A BR0210746A BR 0210746 A BR0210746 A BR 0210746A BR PI0210746 A BRPI0210746 A BR PI0210746A BR 0210746 A BR0210746 A BR 0210746A
Authority
BR
Brazil
Prior art keywords
phosphonomethoxy
alkoxy
antiviral activity
pyrimidine derivatives
compounds
Prior art date
Application number
BR0210746-5A
Other languages
English (en)
Inventor
Jan M R Balzarini
Erik Desire Alice De Clercq
Antonin Holy
Original Assignee
Acad Of Science Czech Republic
Rega Stichting
Jan M R Balzarini
Erik Desire Alice De Clercq
Antonin Holy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acad Of Science Czech Republic, Rega Stichting, Jan M R Balzarini, Erik Desire Alice De Clercq, Antonin Holy filed Critical Acad Of Science Czech Republic
Publication of BR0210746A publication Critical patent/BR0210746A/pt
Publication of BRPI0210746A8 publication Critical patent/BRPI0210746A8/pt
Publication of BRPI0210746B1 publication Critical patent/BRPI0210746B1/pt
Publication of BRPI0210746B8 publication Critical patent/BRPI0210746B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"DERIVADOS DE 6-<39>2-(FOSFONOMETóXI)ALCóXIPIRIMIDINA TENDO ATIVIDADE ANTIVIRAL". São providos compostos tendo a fórmula (I) onde R~ 1~, R~ 2~, R~ 3~, R~ 4~, Z, X e * são definidos aqui. São também providos métodos antivirais para uso e processos para síntese dos compostos da fórmula (I).
BR0210746-5 2001-06-29 2002-06-28 derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação BRPI0210746B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30221201P 2001-06-29 2001-06-29
PCT/CZ2002/000038 WO2003002580A1 (en) 2001-06-29 2002-06-28 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity

Publications (4)

Publication Number Publication Date
BR0210746A true BR0210746A (pt) 2004-07-20
BRPI0210746A8 BRPI0210746A8 (pt) 2018-07-10
BRPI0210746B1 BRPI0210746B1 (pt) 2018-09-18
BRPI0210746B8 BRPI0210746B8 (pt) 2021-05-25

Family

ID=23166777

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210746-5 BRPI0210746B8 (pt) 2001-06-29 2002-06-28 derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação

Country Status (21)

Country Link
US (2) US6818633B2 (pt)
EP (1) EP1406911B1 (pt)
JP (1) JP4545434B2 (pt)
KR (1) KR100891366B1 (pt)
CN (1) CN1329404C (pt)
AP (1) AP1622A (pt)
AU (1) AU2002315625B2 (pt)
BR (1) BRPI0210746B8 (pt)
CA (1) CA2452036C (pt)
CZ (1) CZ297267B6 (pt)
EA (1) EA006020B1 (pt)
ES (1) ES2564144T3 (pt)
HU (1) HU230519B1 (pt)
IL (2) IL159494A0 (pt)
MX (1) MXPA04000138A (pt)
NO (2) NO333788B1 (pt)
NZ (1) NZ530685A (pt)
PL (1) PL207187B1 (pt)
TR (1) TR200302288T2 (pt)
WO (1) WO2003002580A1 (pt)
ZA (1) ZA200400236B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101102815B1 (ko) * 2003-06-16 2012-01-05 케이.유.루벤 리서치 앤드 디벨럽먼트 항바이러스 뉴클레오티드 유사체인 포스포네이트기를 갖는 피리미딘 화합물
US20060211650A1 (en) * 2004-12-16 2006-09-21 Forest Laboratories, Inc. Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
ES2401285T3 (es) 2004-12-16 2013-04-18 The Regents Of The University Of California Fármacos con el pulmón como diana
AU2006272521A1 (en) * 2005-07-27 2007-02-01 Gilead Sciences, Inc. Antiviral phosphonate conjugates for inhibition of HIV
US7473683B2 (en) 2005-09-14 2009-01-06 The Board Of Trustees Of The Leland Stanford Junior University Nonpolar thymidine analogs
US20080318986A1 (en) * 2005-10-13 2008-12-25 Schiffman Rhett M Ddc Compositions
FR2908133B1 (fr) * 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
EP2707004A1 (en) * 2011-05-10 2014-03-19 Okapi Sciences NV Compounds for use in the treatment of feline retroviral infections
ES2687958T3 (es) 2013-03-15 2018-10-30 The Regents Of The University Of California Fosfonato diésteres de nucleósido acíclico
CN104119385B (zh) * 2014-07-24 2017-04-05 廖国超 核苷类似物的磷酸酯前药及其应用
SG11201701957XA (en) 2014-09-15 2017-04-27 Univ California Nucleotide analogs
EP3350191B9 (en) 2015-09-15 2021-12-22 The Regents of the University of California Nucleotide analogs
WO2019206907A1 (en) * 2018-04-23 2019-10-31 Centre National De La Recherche Scientifique New antiviral acyclonucleoside analogues

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263952B1 (en) 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS263951B1 (en) 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS264222B1 (en) 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
NZ222553A (en) 1986-11-18 1991-07-26 Bristol Myers Co Phosphonomethoxyalkylene purine and pyrimidine derivatives and pharmaceutical compositions
CA2001715C (en) 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
CA2479846C (en) 1989-05-15 2007-07-24 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Scienc Es Of The Czech Republic Phosphonomethoxymethylpurine/pyrimidine derivatives
MY104575A (en) 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
CZ285420B6 (cs) 1990-04-24 1999-08-11 Ústav Organické Chemie A Biochemie Avčr N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití
US5356886A (en) 1990-07-19 1994-10-18 Beecham Group P.L.C. Antiviral phosphono-alken derivatives of purines
EP0468119A1 (en) 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
DK0481214T3 (da) 1990-09-14 1999-02-22 Acad Of Science Czech Republic Prolægemidler af phosphonater
US5208221A (en) 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
CZ284678B6 (cs) 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
EP0531597A1 (en) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
JP3497505B2 (ja) 1991-10-11 2004-02-16 インスティテュート オブ オルガニック ケミストリー アンド バイオケミストリー オブ ザ アカデミー オブ サイエンシズ オブ ザ チェコ パブリック 抗ウイルス性非環式ホスホノメトキシアルキル置換アルケニル及びアルキニルプリン及びピリミジン誘導体
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
EP0618214A1 (en) 1993-04-01 1994-10-05 Merrell Dow Pharmaceuticals Inc. Unsaturated phosphonate derivatives of purines and pyrimidines
JP4086314B2 (ja) 1993-09-17 2008-05-14 ギリアード サイエンシーズ， インコーポレイテッド ヌクレオチドアナログ
US5977061A (en) 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use

Also Published As

Publication number Publication date
HUP0400345A3 (en) 2007-05-29
US6818633B2 (en) 2004-11-16
HU230519B1 (hu) 2016-10-28
CZ297267B6 (cs) 2006-10-11
TR200302288T2 (tr) 2004-12-21
EP1406911A1 (en) 2004-04-14
BRPI0210746B8 (pt) 2021-05-25
EP1406911B1 (en) 2016-01-06
CN1533397A (zh) 2004-09-29
IL159494A (en) 2008-06-05
CN1329404C (zh) 2007-08-01
BRPI0210746A8 (pt) 2018-07-10
KR20040027521A (ko) 2004-04-01
BRPI0210746B1 (pt) 2018-09-18
EA200400117A1 (ru) 2004-08-26
MXPA04000138A (es) 2005-06-06
ZA200400236B (en) 2004-08-18
KR100891366B1 (ko) 2009-04-02
AP2004002953A0 (en) 2004-03-31
WO2003002580A8 (en) 2003-01-30
IL159494A0 (en) 2004-06-01
ES2564144T3 (es) 2016-03-18
PL366852A1 (en) 2005-02-07
JP4545434B2 (ja) 2010-09-15
US20030109499A1 (en) 2003-06-12
NO20035797L (no) 2004-02-24
NO20131091L (no) 2004-02-24
AU2002315625B2 (en) 2008-05-01
JP2005511490A (ja) 2005-04-28
CA2452036A1 (en) 2003-01-09
PL207187B1 (pl) 2010-11-30
EA006020B1 (ru) 2005-08-25
HUP0400345A2 (hu) 2004-09-28
AP1622A (en) 2006-06-16
CA2452036C (en) 2009-09-29
WO2003002580A1 (en) 2003-01-09
CZ2004142A3 (cs) 2004-05-12
NO335725B1 (no) 2015-02-02
NZ530685A (en) 2006-09-29
NO333788B1 (no) 2013-09-16
US20050038058A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
BR9914221A (pt) Derivados de glicopeptìdeos e composições farmacêuticas contendo os mesmos
ES2182234T3 (es) Inhibidores de metaloproteasa.
PT1453512E (pt) Derivados de acetileno tendo actividade antagonistica do mglur 5
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE215954T1 (de) Pyrazolo(4,3-d)pyrimidin-derivate und diese enthaltende pharmazeutische zubereitungen
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
NO982606L (no) Naftylsubstituerte benzimidazolderivater som antikoagulanter
FI19992555A (fi) Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
RS49673B (sr) Inhibitori sintaze azot-monoksida
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
ES2243579T3 (es) Derivados de pirazolopirideno.
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
BR0210746A (pt) Derivados de 6-&#39;2-(fosfonometóxi)alcóxi-pirimidina tendo atividade antiviral
DE60031886D1 (de) Purinderivate
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
SE9904128D0 (sv) Novel compounds
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ATE282611T1 (de) Stolonoxide
ECSP992848A (es) Benzotiadiazoles y derivados
RS50412B (sr) Derivati tiazofurina
ECSP972175A (es) DERIVADOS DE BENZO (g) QUINOLINA

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07F 9/6512; A61K 31/675; A61P 31/18, 31/20, 31/12

Ipc: C07F 9/6512 (2011.01), A61K 31/675 (2011.01), A61P

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/09/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/06/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 28/06/2022